Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Scribed by Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valerie; Lebeau, Bernard; Vaylet, Fabien; Barlési, Fabrice; Urban, Thierry; Souquet, Pierre-Jean; Debieuvre, Didier; Baudrin, Laurence; Zalcman, Gérard; Morin, Franck; Milleron, Bernard; Moro-Sibilot, Denis

• Book ID: 119320363
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 483 KB
• Volume: 70
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2010.03.003